Phase 3, Double-blind, Randomized, Active-controlled (Part 1) and Open-labeled, Historical Placebo Controlled (Part 2) Study to Evaluate the Efficacy of Hunterase (Idursulfase-beta) in Hunter Syndrome (Mucopolysaccharidosis II) Patients
Latest Information Update: 04 Jun 2025
At a glance
- Drugs Idursulfase (Primary)
- Indications Mucopolysaccharidosis II
- Focus Therapeutic Use
- Sponsors GC Biopharma
Most Recent Events
- 30 May 2025 According to GC Biopharma media release, results from this study have been published in Genetics in Medicine, an SCIE-indexed journal.
- 30 May 2025 Results presented in the GC Biopharma Media Release
- 14 Apr 2024 Status changed from recruiting to completed.